Trial status
MAY, RECRUITMENT
Protocol version 2, 20-01-2022. The trial is currently in the recruitment phase. The first patient was recruited on 27 October 2021. Thirteen of 112 patients were included in the study on 11 May 2022. Approximate date of trial completion: 27-10-2023.